Figure 1.
Figure 1. Progressive MPN in ΔHmga2/JAK2V617F mice. (A) Schematic diagram of the experiment. WT, ΔHmga2 (H), JAK2V617F (J), and ΔHmga2/JAK2V617F (HJ) mice were obtained in predicted Mendelian ratios. The analyses were performed at 12 weeks old. (B) Complete blood cell counts (means ± standard error of the mean [SEM]) and (C) fractions of white blood cells (%) in 5 WT, 7 H, 5 J, and 4 HJ mice. *P < .05; **P < .01; ***P < .001 calculated by the Tukey-HSD test. (D) May-Giemsa stains of peripheral blood samples (original magnification ×1000). Scale bars indicate 50 µm. (E) Survival periods. N = 9 for WT, 9 H, 12 J, and 7 HJ mice. The P values were calculated by a log-rank test. Bas, basophil; Eos, eosinophil; Hb, hemoglobin concentration (g/dL); Lym, lymphocyte; Mon, monocyte; Neu, neutrophil; OS, overall survival; PLT, platelet count (×1011/L); RBC, red blood cell count (×1012/L); WBC, white blood cell count (×109/L).

Progressive MPN in ΔHmga2/JAK2V617Fmice. (A) Schematic diagram of the experiment. WT, ΔHmga2 (H), JAK2V617F (J), and ΔHmga2/JAK2V617F (HJ) mice were obtained in predicted Mendelian ratios. The analyses were performed at 12 weeks old. (B) Complete blood cell counts (means ± standard error of the mean [SEM]) and (C) fractions of white blood cells (%) in 5 WT, 7 H, 5 J, and 4 HJ mice. *P < .05; **P < .01; ***P < .001 calculated by the Tukey-HSD test. (D) May-Giemsa stains of peripheral blood samples (original magnification ×1000). Scale bars indicate 50 µm. (E) Survival periods. N = 9 for WT, 9 H, 12 J, and 7 HJ mice. The P values were calculated by a log-rank test. Bas, basophil; Eos, eosinophil; Hb, hemoglobin concentration (g/dL); Lym, lymphocyte; Mon, monocyte; Neu, neutrophil; OS, overall survival; PLT, platelet count (×1011/L); RBC, red blood cell count (×1012/L); WBC, white blood cell count (×109/L).

Close Modal

or Create an Account

Close Modal
Close Modal